For significant impacts to the fields of synthetic biology and biological interfaces, innovations in the use of chemistry and nanotechnology to develop a molecular mechanistic understanding of complex biological systems, and pioneering approaches in chemical imaging through integration with mass spectrometry-based detection.
Filter Corporate Fellows
Corporate Fellow Type
Year
All Corporate Fellow summaries reflect the awardee and ORNL at the time the fellowship was awarded.
2021
For his pioneering efforts in silicon carbide–based power electronics, which have paved the way for vehicle and grid infrastructure advancements, enabling transformational achievements in wireless power transfer and electric drivetrain applications, and for the continuing significant impact his accomplishments will have on the global move toward the electrification and decarbonization of the mobility sector.
2014
Jerry is recognized for distinguished research on the genetic basis of tree growth and development, including leading the international efforts to sequence, assemble, and annotate the genomes of poplar and eucalyptus bioenergy feedstocks.
2012
For environmental-effects research related to energy technologies and their use, focusing on the impacts of climate and atmospheric changes on the physiology, growth, and biogeochemical cycles of North American forest ecosystems.
For pioneering research and development of new materials for advanced energy technologies, including materials for (a) the storage of nuclear waste, (b) the solid-state generation of electrical power directly from heat, and (c) the lossless transport of electricity.
2007
For his pioneering contributions to the study of nonequilibrium systems, quantum magnetism, and excitations in condensed matter.
1999
For distinguished contributions to energy policy research and analysis for transportation, and for advancing understanding of the transportation sector's role in energy and environmental concerns.
For fundamental research establishing fission-imposed limits on rotating nuclei, and for extensive studies of heavy ion reactions from low to ultrarelativistic energies.
1998
For international leadership in developing innovative therapeutic and diagnostic applications of radionuclides for nuclear medicine.
1988
For advances in protein structure and enzyme mechanisms by use of affinity labeling and site-directed mutagenesis.